Read + Share
Amedeo Smart
Independent Medical Education
Shu T, Zhou Z, Bai J, Xiao X, et al. Circulating T-cell receptor diversity as predictive biomarker for PARP inhibitors maintenance therapy in high grade serous ovarian cancer. Gynecol Oncol 2022;168:135-143.PMID: 36442424
Email
LinkedIn
Facebook
Twitter
Privacy Policy